Marc Ullman was quoted in the Natural Products Insider article, “FDA written enforcement discretion on CBD unlikely.”

The article discusses how the FDA is unlikely to issue a formal policy of enforcement discretion for CBD-containing products marketed as dietary supplements.

Ullman doesn’t believe the agency would issue a CBD enforcement discretion policy similar to NAC.

Marc Ullman commented on the FDA’s recent announcement that it will exercise enforcement discretion on the use of NAC in the NutraIngredientsUSA article, “FDA formally announces NAC enforcement, but legal handover remains.”

The draft guidance came in response to two petitions, one referencing the DSHEA grandfather date of 1994. The FDA rejected the grandfather date

Marc Ullman will be presenting at the Dietary Supplement Good Manufacturing Practices (GMP) Compliance Virtual Seminar.

The event will be held on May 3, 5, 10, and 12, 2022. Ullman will be presenting with Tara Lin Couch, Ph.D., EAS Senior Director for Dietary Supplement and Tobacco Services, and Tamika Cathey, EAS Independent Consultant.

At the Dietary

Marc Ullman was cited in the NutraIngredients-USA article, “Navigating the legal landscape of weight loss supplements.”

The article explains that since over 42% of adults in the United States are obese, the weight loss industry has an easier time marketing their products. However, this category of supplements has a checkered history and their claims are

Marc Ullman talked with Nutraingredients-USA for the article, “Sixth time still not a charm: FDA again rejects NDIN for Kratom.”

Despite five prior attempts, FDA rejected the latest New Dietary Ingredient (NDI) notification for kratom. American Botanicals Corp. filed three of the six, and the most recent filing is the topic of this article.

Marc

The Nutraingredients-USA article, “Bar association panel takes FDA to task over NDI enforcement,” details a January 29, 2022, New York Bar Association online panel discussion moderated by Marc Ullman. The program was intended to review the current status of the New Dietary Ingredient provision of the Dietary Supplement Health and Education Act of 1994 (DSHEA).

Marc Ullman was featured in the Whole Foods Magazine article, “Industry Members Call FDA Inaction “Disheartening.”

The article mentions the 2022 NYSBA Annual Meeting and explains how the panel discussion focused on intellectual property and FDA’s protection of it, or lack thereof. Ullman moderated the meeting and opened with a story about a dietary supplement

Rivkin Radler is pleased to announce that Christina M. Bezas has been elected to the Caumsett Foundation Board of Directors, where she will serve a three-year term. The Caumsett Foundation’s mission is to support and enhance Caumsett State Historic Park Preserve as a unique and historic environment. The 100% volunteer-run 501(c)(3) organization was formed by

Marc Ullman will be moderating the presentation, “FDA, New Dietary Ingredients, and Intellectual Property: Recent Developments in a Difficult Area” at the New York State Bar Association Annual Meeting of the Food, Drug and Cosmetic Law Section.

Friday, January 28, 2022 at 2:00 PM

The Dietary Supplement Industry has long struggled with issues surrounding its

Evan H. Krinick, Managing Partner of Rivkin Radler LLP, has announced that Ada Janocinska, Justin Piccione and Michael Vanunu have been elected Partners.

“This new class of partners is truly representative of our approach to client service,” Krinick said. “They are skilled lawyers who maintain an unwavering focus on their clients’ goals.”

Ada Janocinska, of